One plan - full access

No subscription, no auto-renewal, no hidden terms.
Pay once and use it for 30 days.

PRO plan No auto-renewal
$18

30 days of full access
One-time payment

🌐 US & Global Companies
Get access for 30 days →
♧ Secure payment · Instant access

What is included

  • ✓Full access to detailed company analysis
  • ✓Fundamental screener
  • ✓Advanced stock screener filters
  • ✓5 ratings. Separate lists for US & Global Companies and MOEX
  • ✓Company data export in XLSX and CSV
  • ✓MarketCap’s overall ranking of top companies
  • ✓Analytics updates after each new financial report
⚠ The service is not an investment advisor. Financial statement data from public companies is available to everyone - MarketCap structures and analyzes it.
American Well Corporation logo
American Well Corporation AMWL
$ 10.75 -1.29%
report update icon

Quarterly report 2026-Q3
added 11-03-2026

American Well Corporation Balance Sheet 2025-2011 | AMWL

Brief balance sheet overview of American Well Corporation

Balance sheet changes are traced across five available annual reports between 2021 and 2025.

Assets finished at $323.8 million versus $1.4 billion initially, losing -77.6%. The balance sheet contracted.

Liabilities grew faster than assets: -58.9% versus -77.6%. A substantial part of expansion was externally funded.

Equity funds 72.8% of assets versus 87.2% initially. This creates a conservative balance sheet structure.

Net debt moved below zero to -$177.8 million, reflecting surplus cash over debt.

The cash reserve occupies 56.3% of the balance sheet, previously 51.6%. It is one marker of short-term resilience.

The balance sheet carries negative retained earnings of -$2.1 billion. The figure may result from accumulated losses or an active capital return policy.

Conclusion

American Well Corporation's financial structure is not clear-cut. Asset scale alone does not resolve questions about how those assets are funded.

Annual Balance Sheet American Well Corporation

2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Net Debt

-178 M -220 M -360 M -524 M -730 M -934 M -124 M -48 M - - - - - - -

Long Term Debt

892 K 4.51 M 8.21 M 11.8 M 14.7 M 1.3 M - - - - - - - - -

Long Term Debt Current

3.63 M 3.69 M 3.58 M 3.06 M 1.92 M 6.36 M - - - - - - - - -

Total Non Current Liabilities

2.78 M 8.46 M 15.7 M 19.6 M 43.3 M 9.47 M 674 M 606 M - - - - - - -

Total Current Liabilities

73.2 M 111 M 93.8 M 114 M 142 M 121 M - - - - - - - - -

Total Liabilities

76 M 120 M 110 M 134 M 185 M 130 M 781 M 694 M - - - - - - -

Deferred Revenue

22.6 M 53.2 M 46.4 M 49.5 M 68.8 M 66.7 M 66.5 M 64.1 M - - - - - - -

Retained Earnings

-2.06 B -1.97 B -1.76 B -1.08 B -811 M -582 M -358 M -271 M - - - - - - -

Total Assets

324 M 436 M 590 M 1.22 B 1.45 B 1.38 B 500 M 489 M - - - - - - -

Cash and Cash Equivalents

182 M 228 M 372 M 539 M 746 M 942 M 138 M 54.1 M - - - - - - -

Book Value

248 M 316 M 480 M 1.08 B 1.26 B 1.25 B -281 M -204 M - - - - - - -

Total Shareholders Equity

236 M 305 M 464 M 1.06 B 1.24 B 1.22 B -281 M -204 M - - - - - - -

All numbers in USD currency

Quarterly Balance Sheet American Well Corporation

2026-Q3 2026-Q2 2026-Q1 2025-Q4 2025-Q3 2025-Q2 2025-Q1 2024-Q4 2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Long Term Debt

- - - 892 K 1.78 M 2.69 M 3.57 M 4.51 M 5.44 M 6.36 M 7.29 M 8.21 M 9.09 M 10 M 10.8 M 11.8 M 12.2 M 12.8 M 13.7 M 14.7 M 15 M 776 K 970 K 1.3 M 3.06 M 1.3 M 1.3 M 7.16 M 7.16 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Total Non Current Liabilities

1.34 M 1.61 M 2.07 M 2.78 M 5.58 M 6.17 M 6.97 M 8.46 M 10.8 M 12.1 M 16.6 M 15.7 M 16.6 M 18.2 M 20.6 M 19.6 M 21.8 M 21.3 M 24.2 M 43.3 M 59.6 M 8.33 M 8.47 M 9.47 M 10.7 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Total Liabilities

84 M 92.9 M 85.8 M 76 M 92.1 M 94.1 M 114 M 120 M 133 M 130 M 125 M 110 M 115 M 128 M 136 M 134 M 127 M 138 M 153 M 185 M 187 M 99.7 M 107 M 130 M 117 M 130 M 130 M 125 M 125 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Deferred Revenue

20.7 M 26.2 M 29.7 M 22.6 M 29.5 M 41.1 M 57.4 M 53.2 M 62.5 M 64.3 M 59.1 M 46.4 M 53.1 M 60.2 M 65.6 M 49.5 M 50.2 M 64 M 68.8 M 68.8 M 60.9 M 57.8 M 63.2 M 66.7 M 54.3 M 66.7 M 66.7 M 66.5 M 66.5 M - - 64.1 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Retained Earnings

-2.09 B -2.08 B -2.07 B -2.06 B -2.04 B -2 B -1.98 B -1.97 B -1.92 B -1.88 B -1.83 B -1.76 B -1.71 B -1.57 B -1.48 B -1.08 B -1.02 B -950 M -881 M -811 M -762 M -709 M -669 M -582 M -532 M -582 M -582 M -358 M -358 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Total Assets

309 M 327 M 326 M 324 M 359 M 389 M 419 M 436 M 483 M 508 M 548 M 590 M 635 M 772 M 851 M 1.22 B 1.23 B 1.3 B 1.36 B 1.45 B 1.48 B 1.29 B 1.32 B 1.38 B 1.41 B 1.38 B 1.38 B 500 M 500 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Cash and Cash Equivalents

182 M 197 M 180 M 183 M 202 M 220 M 223 M 229 M 245 M 278 M 309 M 373 M 320 M 162 M 114 M 539 M 333 M 258 M 178 M 747 M 791 M 976 M 897 M 943 M 958 M 942 M 942 M 138 M 138 M - - 48 M - - - 95.8 M - - - - - - - - - - - - - - - - - - - - - - - - - - -

Book Value

225 M 234 M 240 M 248 M 267 M 295 M 306 M 316 M 350 M 378 M 423 M 480 M 520 M 644 M 714 M 1.08 B 1.1 B 1.16 B 1.21 B 1.26 B 1.3 B 1.19 B 1.22 B 1.25 B 1.3 B 1.25 B 1.25 B 375 M 375 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Total Shareholders Equity

225 M 234 M 240 M 248 M 267 M 295 M 306 M 316 M 350 M 378 M 423 M 480 M 520 M 644 M 714 M 1.08 B 1.1 B 1.16 B 1.21 B 1.26 B 1.3 B 1.19 B 1.22 B 1.25 B 1.3 B 1.22 B 1.22 B -307 M -307 M -241 M -223 M -204 M - - - -162 M - - - - - - - - - - - - - - - - - - - - - - - - - - -

All numbers in USD currency

Balance Sheet is a fundamental financial report of American Well Corporation, providing a complete picture of the company’s financial position at a specific point in time. Unlike the income statement, which records the results of operations over a certain period, the balance sheet shows what assets the company owns, what liabilities it has to creditors, and what equity is available to the owners.

For an investor, the balance sheet is important because it allows assessing the company’s financial stability, understanding how much debt it carries, and how dependent it is on borrowed financing. It helps calculate key liquidity and leverage ratios. When analyzing, attention should be paid to the debt-to-equity ratio (Debt/Equity), the amount of cash on the balance sheet, and the ratio of current liabilities to liquid assets.

Features of balance sheet analysis
  • Vertical and horizontal analysis
    Vertical analysis shows the structure of the balance sheet as a percentage of total assets or liabilities, while horizontal analysis shows the dynamics of changes over multiple periods.
  • Asset quality
    It is important to evaluate not only the amount of assets but also their liquidity and realizability.
  • Accounting for off-balance sheet liabilities
    Some liabilities may not be directly reflected in the balance sheet, which requires additional attention.

Balance sheet of other industry stocks – Health information services

Issuer Price % 24h Market Cap Country
1Life Healthcare 1Life Healthcare
ONEM
- - $ 3.37 B usaUSA
NantHealth NantHealth
NH
- -46.64 % $ 10.4 M usaUSA
Change Healthcare Change Healthcare
CHNG
- - $ 9.03 B usaUSA
Covetrus Covetrus
CVET
- - $ 2.94 B usaUSA
R1 RCM R1 RCM
RCM
- - $ 3.81 B usaUSA
Tabula Rasa HealthCare Tabula Rasa HealthCare
TRHC
- - $ 255 M usaUSA
Cerner Corporation Cerner Corporation
CERN
- - $ 27.9 B usaUSA
Accolade Accolade
ACCD
- 0.29 % $ 206 M usaUSA
Signify Health Signify Health
SGFY
- -0.02 % $ 7.21 B usaUSA
Allscripts Healthcare Solutions Allscripts Healthcare Solutions
MDRX
- -10.39 % $ 886 M usaUSA
NextGen Healthcare NextGen Healthcare
NXGN
- - $ 1.6 B usaUSA
iCAD iCAD
ICAD
- - $ 102 M usaUSA
OptimizeRx Corporation OptimizeRx Corporation
OPRX
$ 6.63 -5.42 % $ 123 M usaUSA
HealthStream HealthStream
HSTM
$ 26.18 0.15 % $ 786 M usaUSA
Evolent Health Evolent Health
EVH
$ 3.9 14.01 % $ 445 M usaUSA
GoodRx Holdings GoodRx Holdings
GDRX
$ 2.91 -3.64 % $ 1.04 B usaUSA
Castlight Health, Inc. Castlight Health, Inc.
CSLT
- -7.28 % $ 227 M usaUSA
HMS Holdings Corp. HMS Holdings Corp.
HMSY
- - $ 3.29 B usaUSA
Inovalon Holdings, Inc. Inovalon Holdings, Inc.
INOV
- - $ 6.37 B usaUSA
Health Catalyst Health Catalyst
HCAT
$ 1.32 2.33 % $ 92.3 M usaUSA
HealthEquity HealthEquity
HQY
$ 94.7 -2.75 % $ 8.16 B usaUSA
Omnicell Omnicell
OMCL
$ 32.36 -2.47 % $ 1.49 B usaUSA
Veeva Systems Veeva Systems
VEEV
$ 266.16 1.18 % $ 43.6 B usaUSA
Progyny Progyny
PGNY
$ 35.72 0.76 % $ 3.04 B usaUSA
10x Genomics 10x Genomics
TXG
$ 51.71 -9.89 % $ 6.45 B usaUSA
Schrödinger Schrödinger
SDGR
$ 22.92 -12.98 % $ 1.68 B usaUSA
So-Young International So-Young International
SY
$ 1.66 -11.97 % $ 129 M chinaChina
SCWorx Corp. SCWorx Corp.
WORX
$ 1.08 -5.18 % $ 7.86 M usaUSA
Zhongchao Zhongchao
ZCMD
$ 0.78 -3.79 % $ 2.67 M chinaChina
Teladoc Health Teladoc Health
TDOC
$ 7.47 -4.29 % $ 1.32 B usaUSA
Computer Programs and Systems Computer Programs and Systems
CPSI
- 4.4 % $ 133 M usaUSA
Phreesia Phreesia
PHR
$ 11.41 -4.0 % $ 682 M usaUSA
Akerna Corp. Akerna Corp.
KERN
- - $ 161 M usaUSA
MTBC MTBC
MTBC
- -0.58 % $ 51.7 M usaUSA
Premier Premier
PINC
- - $ 2.33 B usaUSA
Streamline Health Solutions Streamline Health Solutions
STRM
- - $ 21.4 M usaUSA